- Q1 2024 Revolution Medicines Inc Earnings Call TranscriptMay 08, 2024$38.31 (-1.47%)Earnings
- Q4 2023 Revolution Medicines Inc Earnings Call TranscriptFeb 26, 2024$30.38 (+2.15%)Earnings
- Revolution Medicines Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Q3 2023 Revolution Medicines Inc Earnings Call TranscriptNov 06, 2023$21.54 (-2.80%)Earnings
- Revolution Medicines Inc To Discuss ESMO Data Presentation Call TranscriptOct 22, 2023
- Q2 2023 Revolution Medicines Inc Earnings Call TranscriptAug 08, 2023$30.17 (+1.79%)Earnings
- Revolution Medicines Inc To Acquire EQRx Inc Call TranscriptAug 01, 2023
- Revolution Medicines Inc at Barclays Lunchtime Biotech Fireside Chat Series TranscriptJun 15, 2023
- Revolution Medicines Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Q1 2023 Revolution Medicines Inc Earnings Call TranscriptMay 08, 2023$24.44 (+0.41%)Earnings
- Revolution Medicines Inc at Needham Healthcare Conference (Virtual) TranscriptApr 20, 2023
- Q4 2022 Revolution Medicines Inc Earnings Call TranscriptFeb 27, 2023$24.37 (+0.16%)Earnings
- Revolution Medicines Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Revolution Medicines Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Revolution Medicines Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Q2 2022 Revolution Medicines Inc Earnings Call TranscriptAug 09, 2022$23.76 (-2.62%)Earnings
- Revolution Medicines Inc Annual Shareholders Meeting TranscriptJun 16, 2022
- Revolution Medicines Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- Q2 2021 Revolution Medicines Inc Earnings Call TranscriptAug 11, 2021$26.9 (-0.81%)Earnings
- Revolution Medicines Inc at H C Wainwright Global Life Sciences Conference (Virtual) TranscriptMar 09, 2021
- Revolution Medicines Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Revolution Medicines Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
Revolution Medicines Inc at Barclays Lunchtime Biotech Fireside Chat Series Transcript
Good afternoon. My name is Peter Lawson. I'm one of the biotech analysts at Barclays. Welcome to Lawson's Lunchtime Deep Dive with Revolution Medicines. Goal of these calls is to help preview upcoming data and we've been doing it for the last 3 years at Barclays and Revolution Medicines [attending] our series, and I think we've got the 4 left this year for the series.
And I hope you find them useful and of course, [II season] and so we very much appreciate all those are support. And just as a way of orientation, this is a 30-minute call, if you have questions, do e-mail me directly. So at [email protected], you can get me on Bloomberg. I'm on Bloomberg, so you can pass me that way.
And -- the others -- and it gives me great pleasure here to introduce Revolution Medicines. We don't cover the company, so uncovered. So thanks so much, Mark Goldsmith, CEO. Thanks for your time today and you have time permitting, we'd love to cover the multi-RAS inhibitor updated data in the second half and then your G12C.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)